SE506533C2 - En process för in vitro analys av substansers toxiska och allergena egenskaper samt användning av neopterin för att skilja mellan allergiska immunreaktioner - Google Patents

En process för in vitro analys av substansers toxiska och allergena egenskaper samt användning av neopterin för att skilja mellan allergiska immunreaktioner

Info

Publication number
SE506533C2
SE506533C2 SE9502409A SE9502409A SE506533C2 SE 506533 C2 SE506533 C2 SE 506533C2 SE 9502409 A SE9502409 A SE 9502409A SE 9502409 A SE9502409 A SE 9502409A SE 506533 C2 SE506533 C2 SE 506533C2
Authority
SE
Sweden
Prior art keywords
cytokines
class
neopterin
substance
cells
Prior art date
Application number
SE9502409A
Other languages
English (en)
Swedish (sv)
Other versions
SE9502409L (sv
SE9502409D0 (sv
Inventor
Birger Andersson
Original Assignee
Birger Andersson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20398831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE506533(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Birger Andersson filed Critical Birger Andersson
Priority to SE9502409A priority Critical patent/SE506533C2/sv
Publication of SE9502409D0 publication Critical patent/SE9502409D0/xx
Priority to AT96925215T priority patent/ATE239918T1/de
Priority to DE69628033T priority patent/DE69628033T3/de
Priority to US10/115,066 priority patent/USRE38423E1/en
Priority to PCT/SE1996/000902 priority patent/WO1997016732A1/en
Priority to ES96925215T priority patent/ES2198496T5/es
Priority to DK96925215T priority patent/DK0866968T4/da
Priority to CA002236474A priority patent/CA2236474A1/en
Priority to EP96925215A priority patent/EP0866968B2/en
Priority to AU65379/96A priority patent/AU724932B2/en
Priority to US09/066,292 priority patent/US6046010A/en
Priority to JP9517257A priority patent/JP2000500330A/ja
Publication of SE9502409L publication Critical patent/SE9502409L/xx
Publication of SE506533C2 publication Critical patent/SE506533C2/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE9502409A 1995-07-03 1995-07-03 En process för in vitro analys av substansers toxiska och allergena egenskaper samt användning av neopterin för att skilja mellan allergiska immunreaktioner SE506533C2 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9502409A SE506533C2 (sv) 1995-07-03 1995-07-03 En process för in vitro analys av substansers toxiska och allergena egenskaper samt användning av neopterin för att skilja mellan allergiska immunreaktioner
JP9517257A JP2000500330A (ja) 1995-07-03 1996-07-03 毒性物質及びアレルゲン性物質の生体外分析のための方法
US09/066,292 US6046010A (en) 1995-07-03 1996-07-03 Process for in vitro analysis of toxic and allergenic substances
ES96925215T ES2198496T5 (es) 1995-07-03 1996-07-03 Un procedimiento para analisis in vitro de sustancias toxicas y alergenicas.
DE69628033T DE69628033T3 (de) 1995-07-03 1996-07-03 Verfahren zur in vitro-analyse von toxischen und allergenen substanzen
US10/115,066 USRE38423E1 (en) 1995-07-03 1996-07-03 Process for in vitro analysis of toxic and allergenic substances
PCT/SE1996/000902 WO1997016732A1 (en) 1995-07-03 1996-07-03 A process for in vitro analysis of toxic and allergenic substances
AT96925215T ATE239918T1 (de) 1995-07-03 1996-07-03 Verfahren zur im-vitro-analyse von toxischen und allergenen substanzen
DK96925215T DK0866968T4 (da) 1995-07-03 1996-07-03 Fremgangsmåde til in vitro analyse af toksiske og allergene stoffer
CA002236474A CA2236474A1 (en) 1995-07-03 1996-07-03 A process for in vitro analysis of toxic and allergenic substances
EP96925215A EP0866968B2 (en) 1995-07-03 1996-07-03 A process for in vitro analysis of toxic and allergenic substances
AU65379/96A AU724932B2 (en) 1995-07-03 1996-07-03 A process for in vitro analysis of toxic and allergenic substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9502409A SE506533C2 (sv) 1995-07-03 1995-07-03 En process för in vitro analys av substansers toxiska och allergena egenskaper samt användning av neopterin för att skilja mellan allergiska immunreaktioner

Publications (3)

Publication Number Publication Date
SE9502409D0 SE9502409D0 (sv) 1995-07-03
SE9502409L SE9502409L (sv) 1997-05-02
SE506533C2 true SE506533C2 (sv) 1998-01-12

Family

ID=20398831

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9502409A SE506533C2 (sv) 1995-07-03 1995-07-03 En process för in vitro analys av substansers toxiska och allergena egenskaper samt användning av neopterin för att skilja mellan allergiska immunreaktioner

Country Status (11)

Country Link
US (1) US6046010A (enExample)
EP (1) EP0866968B2 (enExample)
JP (1) JP2000500330A (enExample)
AT (1) ATE239918T1 (enExample)
AU (1) AU724932B2 (enExample)
CA (1) CA2236474A1 (enExample)
DE (1) DE69628033T3 (enExample)
DK (1) DK0866968T4 (enExample)
ES (1) ES2198496T5 (enExample)
SE (1) SE506533C2 (enExample)
WO (1) WO1997016732A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009077602A1 (en) 2007-12-18 2009-06-25 Biovator Technologies Ab Improved assay
EP2108959A1 (en) 2005-09-16 2009-10-14 Biovator Technologies AB In vitro assay for identification of allergenic proteins

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2384141A1 (en) * 1999-10-15 2001-04-26 Novozymes A/S A method for the assessment of allergenicity
US7415358B2 (en) 2001-05-22 2008-08-19 Ocimum Biosolutions, Inc. Molecular toxicology modeling
US20030022250A1 (en) * 2001-05-29 2003-01-30 Dreskin Stephen C. Functional IgE test methods and compositions
US7447594B2 (en) 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
US7469185B2 (en) 2002-02-04 2008-12-23 Ocimum Biosolutions, Inc. Primary rat hepatocyte toxicity modeling
US20040077104A1 (en) * 2002-07-09 2004-04-22 Valentino Montegrande Antigen detection device
PL1708690T3 (pl) 2003-11-17 2017-01-31 Biomarin Pharmaceutical Inc. Leczenie fenyloketonurii za pomocą BH4
CN101132776A (zh) * 2004-11-17 2008-02-27 生物马林药物股份有限公司 稳定的四氢生物喋呤片剂制剂
EP1905843A1 (en) * 2006-09-29 2008-04-02 Vlaamse Instelling voor Technologisch Onderzoek Method for determining the allergic potential of a compound
JP5442185B2 (ja) * 2007-04-24 2014-03-12 日本メナード化粧品株式会社 感作性物質評価方法
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
CN109283210B (zh) * 2017-07-20 2021-02-09 郭俊成 一种应用植物胶琼脂固化而快速简便检测毒性物质的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4215275A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Mittel und Verfahren zur Behandlung von Körperflüssigkeiten bei der Bestimmung von Neopterin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2108959A1 (en) 2005-09-16 2009-10-14 Biovator Technologies AB In vitro assay for identification of allergenic proteins
WO2009077602A1 (en) 2007-12-18 2009-06-25 Biovator Technologies Ab Improved assay

Also Published As

Publication number Publication date
CA2236474A1 (en) 1997-05-09
DK0866968T4 (da) 2009-06-22
DE69628033T8 (de) 2005-03-10
US6046010A (en) 2000-04-04
DE69628033T3 (de) 2009-11-19
SE9502409L (sv) 1997-05-02
ES2198496T3 (es) 2004-02-01
DE69628033T2 (de) 2004-04-22
AU6537996A (en) 1997-05-22
EP0866968A1 (en) 1998-09-30
DE69628033D1 (de) 2003-06-12
EP0866968B2 (en) 2009-05-06
JP2000500330A (ja) 2000-01-18
SE9502409D0 (sv) 1995-07-03
WO1997016732A1 (en) 1997-05-09
AU724932B2 (en) 2000-10-05
DK0866968T3 (da) 2003-09-01
ATE239918T1 (de) 2003-05-15
EP0866968B1 (en) 2003-05-07
ES2198496T5 (es) 2009-10-23

Similar Documents

Publication Publication Date Title
SE506533C2 (sv) En process för in vitro analys av substansers toxiska och allergena egenskaper samt användning av neopterin för att skilja mellan allergiska immunreaktioner
JP5675638B2 (ja) アレルギー反応を診断するための方法
Stoneham et al. Measurement of serum amyloid A in the neonatal foal using a latex agglutination immunoturbidimetric assay: determination of the normal range, variation with age and response to disease
CN112331344B (zh) 免疫状态评估方法及应用
US6642012B1 (en) Spectroscopic determination of characteristic of biological material
Clements et al. Andrology: Implementing comprehensive quality control in the andrology laboratory
CN111128378A (zh) 一种用于评估婴幼儿肠道菌群发育年龄的预测方法
JP4272431B2 (ja) 診断試験法
Corsini et al. Evaluating cytokines in immunotoxicity testing
JP2011505858A (ja) 改善されたアッセイ
USRE38423E1 (en) Process for in vitro analysis of toxic and allergenic substances
Corsini et al. Evaluating cytokines in immunotoxicity testing
RU2104542C1 (ru) Способ оценки резистентности организма
JP2007513399A (ja) 生化学画像の生成及びその使用方法
Fleisher Evaluation of suspected immunodeficiency
RU2275634C2 (ru) Способ прогнозирования течения острых кишечных инфекций у детей
CN113295496B (zh) 一种风湿病患者细胞因子流式检测的样本前处理及保存方法
RU2098824C1 (ru) Способ определения кишечных инфекций
Kalaydjiev et al. Mouse phenotyping: immunology
RU2105975C1 (ru) Способ определения фагоцитарной активности периферической крови
Acevedo et al. Mass Cytometry in Food Allergy Research
EP2662691A1 (en) Basophil and high affinity IgE receptor materials and methods relating to the diagnosis of anaphylaxis
CA2536698A1 (en) System and method of detecting, identifying and characterizing pathogensand characterizing hosts
RU2052205C1 (ru) Способ диагностики инфекционной резистентности организма
Joyce et al. A system for assessment of monokine gene expression using human whole blood

Legal Events

Date Code Title Description
NUG Patent has lapsed